Target type: biologicalprocess
The process in which immunoglobulin heavy chain V, D, and J gene segments are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS). [GOC:add, ISBN:0781735149]
Immunoglobulin heavy chain V-D-J recombination is a complex process that generates a diverse repertoire of antibodies. It occurs in developing B lymphocytes and involves the rearrangement of three gene segments: V (variable), D (diversity), and J (joining). This rearrangement is essential for creating the unique antigen-binding sites of antibodies.
The process begins with the transcription of the immunoglobulin heavy chain locus, which contains multiple copies of V, D, and J gene segments. These segments are flanked by recombination signal sequences (RSS), which are conserved DNA motifs that guide the recombination process.
**1. RAG Recombinase Activity:**
* The recombination process is initiated by the RAG1 and RAG2 enzymes (Recombination Activating Genes).
* These enzymes recognize and bind to the RSSs flanking the V, D, and J segments.
* RAG1 cleaves the DNA at the RSS, creating a hairpin loop structure at the end of the DNA segment.
**2. VDJ Joining:**
* The cleaved DNA segments are then processed by a series of enzymes, including DNA-PKcs, Artemis, and Ku70/Ku80.
* These enzymes open the hairpin loops and process the DNA ends to create a single-stranded overhang.
* The overhangs are then joined together by the enzyme DNA ligase IV, forming a V-D-J rearrangement.
**3. Diversity Generation:**
* During the process of V-D-J recombination, several mechanisms contribute to antibody diversity:
* **Multiple Gene Segments:** The heavy chain locus contains hundreds of V, D, and J gene segments, allowing for a large number of possible combinations.
* **N-Nucleotide Addition:** Terminal deoxynucleotidyl transferase (TdT) randomly adds nucleotides to the ends of the rearranged segments.
* **P-Nucleotide Addition:** The RAG enzymes can add nucleotides to the DNA ends during the hairpin opening process.
**4. Allelic Exclusion:**
* Once a successful V-D-J recombination event occurs on one chromosome, the other chromosome is usually silenced. This ensures that each B cell expresses only one type of immunoglobulin heavy chain, a phenomenon known as allelic exclusion.
**5. Class Switch Recombination:**
* After V-D-J recombination, B cells can undergo class switch recombination, which alters the constant region of the antibody, allowing the cell to produce different antibody isotypes (e.g., IgM, IgG, IgA).
**Overall, V-D-J recombination is a highly regulated and intricate process that ensures the generation of a vast repertoire of antibodies, allowing the immune system to recognize and neutralize a wide range of pathogens.'
"
Protein | Definition | Taxonomy |
---|---|---|
DNA polymerase beta | A DNA polymerase beta that is encoded in the genome of human. [PRO:CNA] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
digallic acid | digallic acid: structure given in first source | benzoate ester; gallate ester | |
pamoic acid | pamoic acid: RN given refers to parent cpd; structure | dicarboxylic acid | |
Dillapiole | 5-allyl 6,7-dimethoxy 1,3-benzodioxole: a plant based insecticide; structure in first source | benzodioxoles | metabolite |
oleanolic acid | hydroxy monocarboxylic acid; pentacyclic triterpenoid | plant metabolite | |
zidovudine | zidovudine : A pyrimidine 2',3'-dideoxyribonucleoside compound having a 3'-azido substituent and thymine as the nucleobase. Zidovudine: A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. | azide; pyrimidine 2',3'-dideoxyribonucleoside | antimetabolite; antiviral drug; HIV-1 reverse transcriptase inhibitor |
ursolic acid | hydroxy monocarboxylic acid; pentacyclic triterpenoid | geroprotector; plant metabolite | |
thymidine 5'-triphosphate | dTTP : A thymidine phosphate having a triphosphate group at the 5'-position. thymidine 5'-triphosphate: RN given refers to parent cpd | pyrimidine 2'-deoxyribonucleoside 5'-triphosphate; thymidine phosphate | Escherichia coli metabolite; mouse metabolite |
betulinic acid | hydroxy monocarboxylic acid; pentacyclic triterpenoid | anti-HIV agent; anti-inflammatory agent; antimalarial; antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; plant metabolite | |
calanolide a | (+)-calanolide A : An organic heterotetracyclic compound that is 11,12-dihydro-2H,6H,10H-dipyrano[2,3-f:2',3'-h]chromen-2-one substituted by a hydroxy group at position 12, methyl groups at positions 6, 6, 10 and 11 and a propyl group at position 4 (the 10R,11S,12S stereoisomer). Isolated from Calophyllum lanigerum var austrocoriaceum and Calophyllum brasiliense, it exhibits potent activity against HIV-1 reverse transcriptase. calanolide A: NSC 661122 and costatolide are isomers; a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum (Clusiaceae); structure in first source | cyclic ether; delta-lactone; organic heterotetracyclic compound; secondary alcohol | HIV-1 reverse transcriptase inhibitor; plant metabolite |
2',3'-dideoxythymidine triphosphate | ddTTP : A pyrimidine 2',3'-dideoxyribonucleoside 5'-triphosphate having thymine as the nucleobase. | pyrimidine 2',3'-dideoxyribonucleoside 5'-triphosphate; thymidine phosphate | |
2',3'-dideoxyadenosine triphosphate | purine deoxyribonucleoside triphosphate | ||
zidovudine triphosphate | |||
illimaquinone | illimaquinone: structure given in first source; isolated from the Red Sea sponge Smenospongia; inhibits the RNase H. activity of HIV-1 reverse transcriptase | monohydroxy-1,4-benzoquinones; prenylquinone | metabolite |
sitosterol, (3beta)-isomer | sitosterol : A member of the class of phytosterols that is stigmast-5-ene substituted by a beta-hydroxy group at position 3. Sobatum: tradename; active fraction of Solanum trilobatum; reduces side-effects of radiation-induced toxicity | 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; C29-steroid; phytosterols; stigmastane sterol | anticholesteremic drug; antioxidant; mouse metabolite; plant metabolite; sterol methyltransferase inhibitor |
TTP | pyrimidine ribonucleoside 5'-triphosphate | ||
aphidicolin | aphidicolin : A tetracyclic diterpenoid that has an tetradecahydro-8,11a-methanocyclohepta[a]naphthalene skeleton with two hydroxymethyl substituents at positions 4 and 9, two methyl substituents at positions 4 and 11b and two hydroxy substituents at positions 3 and 9. An antibiotic with antiviral and antimitotical properties. Aphidicolin is a reversible inhibitor of eukaryotic nuclear DNA replication. Aphidicolin: An antiviral antibiotic produced by Cephalosporium aphidicola and other fungi. It inhibits the growth of eukaryotic cells and certain animal viruses by selectively inhibiting the cellular replication of DNA polymerase II or the viral-induced DNA polymerases. The drug may be useful for controlling excessive cell proliferation in patients with cancer, psoriasis or other dermatitis with little or no adverse effect upon non-multiplying cells. | tetracyclic diterpenoid | antimicrobial agent; antimitotic; antineoplastic agent; antiviral drug; apoptosis inducer; Aspergillus metabolite; DNA synthesis inhibitor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; fungal metabolite |
stigmasterol | stigmasta-5,22-dien-3-ol: isolated from freeze-dried powder of Blackberries (Rubus ursinus L.) which showed an activity on inhibition of chemocarcinogen stigmasterol : A 3beta-sterol that consists of 3beta-hydroxystigmastane having double bonds at the 5,6- and 22,23-positions. | 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; phytosterols; stigmastane sterol | plant metabolite |
lyoniside | daucosterol : A steroid saponin that is sitosterol attached to a beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It has bee isolated from Panax japonicus var. major and Breynia fruticosa. | beta-D-glucoside; monosaccharide derivative; steroid saponin | plant metabolite |
corosolic acid | triterpenoid | metabolite | |
edgeworin | edgeworin: from Dirca occidentalis Gray; structure given in first source | ||
raltegravir | 1,2,4-oxadiazole; dicarboxylic acid amide; hydroxypyrimidine; monofluorobenzenes; pyrimidone; secondary carboxamide | antiviral drug; HIV-1 integrase inhibitor | |
GS-443902 | GS-441524 triphosphate: intracellular active metabolite of remdesivir GS-443902 : An organic triphosphate that is GS-441524 in which the 5'-hydroxy group has been replaced by a triphosphate group. It is the active metabolite of remdesivir. | aromatic amine; C-nucleoside; nitrile; organic triphosphate; pyrrolotriazine | anticoronaviral agent; antiviral drug; drug metabolite |